Transcat, Inc. (NASDAQ:TRNS – Free Report) – Equities research analysts at HC Wainwright lowered their Q3 2025 earnings per share estimates for shares of Transcat in a research note issued to investors on Wednesday, October 30th. HC Wainwright analyst S. Buck now expects that the scientific and technical instruments company will post earnings per share of $0.29 for the quarter, down from their prior estimate of $0.43. HC Wainwright has a “Buy” rating and a $156.00 price objective on the stock. The consensus estimate for Transcat’s current full-year earnings is $2.06 per share. HC Wainwright also issued estimates for Transcat’s FY2025 earnings at $1.60 EPS and FY2026 earnings at $1.83 EPS.
Transcat (NASDAQ:TRNS – Get Free Report) last released its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a return on equity of 7.62% and a net margin of 6.63%. The company had revenue of $67.83 million during the quarter, compared to analyst estimates of $70.30 million. During the same period in the prior year, the business posted $0.41 earnings per share. Transcat’s revenue was up 8.0% on a year-over-year basis.
View Our Latest Stock Analysis on TRNS
Transcat Stock Down 3.5 %
Shares of TRNS opened at $95.57 on Friday. Transcat has a fifty-two week low of $84.45 and a fifty-two week high of $147.12. The company’s fifty day moving average is $122.34 and its two-hundred day moving average is $121.99. The firm has a market cap of $874.47 million, a PE ratio of 48.27 and a beta of 0.67.
Hedge Funds Weigh In On Transcat
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Quadrature Capital Ltd purchased a new position in Transcat in the 1st quarter valued at about $619,000. Calamos Advisors LLC grew its stake in Transcat by 76.0% during the 2nd quarter. Calamos Advisors LLC now owns 15,441 shares of the scientific and technical instruments company’s stock valued at $1,848,000 after purchasing an additional 6,667 shares in the last quarter. First Horizon Advisors Inc. increased its holdings in Transcat by 26.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock worth $72,000 after purchasing an additional 125 shares during the last quarter. Quest Partners LLC purchased a new position in shares of Transcat during the 2nd quarter valued at approximately $109,000. Finally, Annex Advisory Services LLC grew its position in shares of Transcat by 61.4% during the third quarter. Annex Advisory Services LLC now owns 16,568 shares of the scientific and technical instruments company’s stock worth $2,001,000 after buying an additional 6,304 shares in the last quarter. 98.34% of the stock is owned by institutional investors and hedge funds.
About Transcat
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Recommended Stories
- Five stocks we like better than Transcat
- 3 Stocks to Consider Buying in October
- Top Nuclear Stocks Thriving on Soaring Energy Demand
- Find and Profitably Trade Stocks at 52-Week Lows
- Apple Earnings – When Really Good Just Isn’t Good Enough
- What Makes a Stock a Good Dividend Stock?
- Starbucks Stock Primed for Growth Under New CEO Niccol’s Vision
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.